University of GlasgowUniversity Of Glasgow, Glasgow, United Kingdom
Our mission is to provide robust evidence on the causes of mental disorders and conditions and to develop and evaluate innovative treatment approaches for individuals, their families and the broader population.
- Investigating the impact and interaction of psychological, developmental, social, interpersonal, biological, genetic, environmental, lifestyle and health service factors on risk for mental disorder and population mental health.
- Conducting clinical trials of therapeutic and complex interventions for individuals with complex mental health problems including research dedicated to understanding the psychological, social, interpersonal and biological mechanisms of therapeutic change.
Glasgow Research Facility
The Glasgow Clinical Research Facility (GCRF), University of Glasgow (UGLA) was established in 2006 with funding from the Scottish Government via the Chief Scientist Office. It provides state-of-the-art research space across several geographical sites including the £5million Clinical Research Facility at Queen Elizabeth University Hospital Campus. This ensures clinical research is a cornerstone of person-centred healthcare development.
Each research space provides high-quality clinical environments and outreach services where patients and healthy volunteers can take part in international clinical research studies.
The GCRF employs a team of multidisciplinary staff, supporting a portfolio of over 200 clinical research studies, ranging from complex early phase or novel technique experimental medicine to large population-based public health initiatives.
Glasgow Biomedicine academic/ NHS collaboration to provide infrastructure for the delivery of clinical trials. Recruitment of children and adults with ASD into clinical trials via specialist community services for children and adults with ASD; 743 children and adolescents, and 368 adults referred for ASD diagnostic assessment in 2016.
Role in AIMS-2-TRIALS
The main role of the University of Glasgow / Greater Glasgow and Clyde Health Board will be within the Testing New Medicines project. Glasgow will be involved, carry out drug repurposing RCT (RCT1) using a stratified medicine approach.